oseltamivir phosphate

Generic: oseltamivir phosphate

Labeler: teva pharmaceuticals usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name oseltamivir phosphate
Generic Name oseltamivir phosphate
Labeler teva pharmaceuticals usa, inc.
Dosage Form POWDER, FOR SUSPENSION
Routes
ORAL
Active Ingredients

oseltamivir phosphate 6 mg/mL

Manufacturer
Teva Pharmaceuticals USA, Inc.

Identifiers & Regulatory

Product NDC 0093-8180
Product ID 0093-8180_f8f3e33e-61de-4fe8-9a9b-11404ab66ded
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211125
Listing Expiration 2026-12-31
Marketing Start 2019-07-10

Pharmacologic Class

Classes
neuraminidase inhibitor [epc] neuraminidase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00938180
Hyphenated Format 0093-8180

Supplemental Identifiers

RxCUI
1115698
UNII
4A3O49NGEZ

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name oseltamivir phosphate (source: ndc)
Generic Name oseltamivir phosphate (source: ndc)
Application Number ANDA211125 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 6 mg/mL
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (0093-8180-64) / 60 mL in 1 BOTTLE
source: ndc

Packages (1)

Ingredients (1)

oseltamivir phosphate (6 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "f8f3e33e-61de-4fe8-9a9b-11404ab66ded", "openfda": {"unii": ["4A3O49NGEZ"], "rxcui": ["1115698"], "spl_set_id": ["3ea5bf8f-c3fa-4d44-bc3d-b1912374ee4b"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (0093-8180-64)  / 60 mL in 1 BOTTLE", "package_ndc": "0093-8180-64", "marketing_start_date": "20190710"}], "brand_name": "Oseltamivir Phosphate", "product_id": "0093-8180_f8f3e33e-61de-4fe8-9a9b-11404ab66ded", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Neuraminidase Inhibitor [EPC]", "Neuraminidase Inhibitors [MoA]"], "product_ndc": "0093-8180", "generic_name": "Oseltamivir Phosphate", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oseltamivir Phosphate", "active_ingredients": [{"name": "OSELTAMIVIR PHOSPHATE", "strength": "6 mg/mL"}], "application_number": "ANDA211125", "marketing_category": "ANDA", "marketing_start_date": "20190710", "listing_expiration_date": "20261231"}